Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections-Reference-Cited by-同舟云学术

Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections

Published:2023-02-23 Issue:4 Volume:42 Page:481-491
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Marciano Sebastián^ORCID,Gutierrez-Acevedo Maria N.,Barbero Sabrina,del C. Notari Lorena,Agozino Marina,Fernandez Jose L.,Anders Maria M.,Grigera Nadia,Antinucci Florencia,Orozco Ganem Orlando F.,Murga Maria D.,Perez Daniela,Palazzo Ana,Martinez Rejtman Liria,Duarte Ivonne G.,Vorobioff Julio,Trevizan Victoria,Bulaty Sofía,Bessone Fernando,Valverde Marcelo,Elizondo Martín,Bosia José D.,Borzi Silvia M.,Stieben Teodoro E.,Masola Adriano,Ferretti Sebastian E.,Arufe Diego,Demirdjian Ezequiel,Raffa Maria P.,Peralta Mirta,Fainboim Hugo A.,Vazquez Cintia E.,Ruiz Pablo,Martínez José E.,Heffner Leandro A.,Odzak Andrea,Dirchwolf Melisa,Smud Astrid,Mendizabal Manuel,Bellizzi Carla,Martinez Ana,Tomatis Jesica,Bruno Andres,Ramos Agñel,Pages Josefina,Tevez Silvina,Gadano Adrian C.,Giunta Diego H.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04572-2.pdf

Reference22 articles.

1. World Health Organization (2020, July 31). Antibiotic resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance

2. Medina E, Pieper DH (2016) Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol 398:3–33

3. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P et al (2014) Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 60:1310–1324

4. Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R et al (2019) Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe [Internet]. J Hepatol 70:398–411. https://doi.org/10.1016/j.jhep.2018.10.02710.1016/j.jhep.2018.10.027

5. Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J et al (2019) Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 156:1368–80.e10

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards evidence-based empiric antibiotic recommendations for spontaneous infections in patients with cirrhosis;Digestive and Liver Disease;2024-08

2. Multidrug-resistant bacterial infections in the liver transplant setting;Updates in Surgery;2024-06-25

3. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors;Journal of Hepatology;2024-06

4. Predictors and Outcomes of Infections in ICU Patients With Cirrhosis: A Single-Center Observational Study;Cureus;2023-10-16

5. Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota;Antibiotics;2023-09-22